Professional Medical Billing Services for Infectious Disease Physicians

Prior authorization means the insurer requires information and approval before it will consider covering a treatment, drug, procedure, or service. In infectious disease practice, this may apply to infusions, OPAT courses, or specialty drugs. The process can involve confirming eligibility, documenting medical necessity, identifying the applicable medical or pharmacy benefit, and submitting supporting clinical information before therapy is provided.

The process generally begins by verifying eligibility and benefits and determining whether the requested therapy falls under the medical or pharmacy benefit. The practice then gathers clinical documentation, submits the request to the payer, monitors its status, responds to requests for additional information, and records the decision. Tracking each request helps reduce authorization-related delays and unreimbursed drug costs.

Relevant services include claims management, coding review, eligibility and authorization support, denial management, payment reconciliation, A/R follow-up, credentialing, payer enrollment, contract compliance, and revenue-cycle consulting. Infectious disease practices may need support across both cognitive services and infusion or OPAT operations, including drug, administration, E/M, hospital consult, and specialty-drug claims.

Infectious disease practices may combine cognitive physician services with infusion operations, OPAT courses, drug acquisition, and complex payer requirements. Revenue can be affected by documentation, coding, authorization, medical versus pharmacy benefit rules, charge capture, contracts, and payment accuracy. A billing approach tailored to these connected service lines can help identify issues that a general workflow may overlook.

Revenue leakage can be investigated by reviewing documentation, coding, charge capture, payer payments, contracts, denials, and aging A/R. Reporting by payer, service line, and provider can reveal denial patterns, payment trends, missing charges, short-pays, and stalled claims. Tracing each issue back to its source helps practices distinguish isolated errors from workflow or contract problems.

Yes. Infectious disease billing support may include eligibility and authorization work, charge entry, coding review, claim scrubbing, submission, rejection clearing, denial appeals, payment reconciliation, and A/R follow-up for infusion and OPAT services. Drug, administration, and related E/M claims can be reviewed together so the practice can assess whether the full service was captured and reimbursed.

Payment reconciliation compares payer payments with expected reimbursement for drug, administration, and E/M claims. The review may identify short-pays, incorrect fee schedule application, unit mismatches, NDC mismatches, or other payment discrepancies. Findings can then be documented, disputed, and tracked to recovery while recurring payment issues are reported for operational or contract review.

Denial management organizes denials by root cause, such as missing authorization, drug and administration coding, medical versus pharmacy benefit confusion, or under-documented consults. Payer-specific appeals can be supported by clinical documentation, while findings are shared with clinical, coding, and front-office teams. This helps address individual claims and reduce repeat issues in the underlying workflow.